Table 3.
Univariable and multivariable analysis for mortality
| Variable | Univariable analysis | Multivariable analysis | |||
|---|---|---|---|---|---|
|
|
|
||||
| Hazard ratio (95% CI) | p-value | Hazard ratio (95% CI) | p-value | ||
| Age | 1.023 (0.964–1.086) | 0.460 | |||
| FEV1 (% predicted) | 0.992 (0.953–1.032) | 0.695 | |||
| DLCO (% predicted) | 0.972 (0.943–1.002) | 0.064 | 0.980 (0.949–1.012) | 0.212 | |
| Current smoker | 0.698 (0.232–2.067) | 0.692 | |||
| Diabetes mellitus | 1.270 (0.352–4.583) | 0.715 | |||
| Underlying lung disease | 2.538 (0.847–7.604) | 0.096 | 0.908 (0.150–5.493) | 0.917 | |
| Cardiovascular disease | 1.140 (0.393–3.303) | 0.809 | |||
| cTNM stage (cIA vs.) | 0.841 | ||||
| cIB | 0.705 (0.156–3.171) | 0.649 | |||
| cIIA | 1.400 (0.178–11.013) | 0.749 | |||
| Thoracoscopic surgery (vs. thoraocotomy) | 0.967 (0.314–2.975) | 0.953 | |||
| Lobectomy/bilobectomy (vs. sublobar resection) | 0.202 (0.066–0.617) | 0.005 | 0.963 (0.124–8.558) | 0.972 | |
| Complete resection | 0.250 (0.053–1.183) | 0.080 | 1.262 (0.114–8.109) | 0.838 | |
| Mixed histologic type | 1.090 (0.301–3.943) | 0.895 | |||
| pTNM stage (I vs.) | <0.001 | <0.001 | |||
| II | 0.348 (0.043–2.782) | 0.319 | 0.348 (0.43–2.782) | 0.319 | |
| III/IV | 13.216 (3.382–51.646) | <0.001 | 13.216 (3.382–51.646) | <0.001 | |
| Adjuvant chemotherapy | 0.129 (0.104–0.941) | 0.039 | 0.554 (0.163–1.885) | 0.344 | |
| Prophylactic cranial irradiation | 1.881 (0.585–6.052) | 0.289 | |||
CI, confidence interval; FEV1, forced expiratory volume in 1 second; DLCO, carbon monoxide lung diffusion capacity; TNM, tumor-node-metastasis; cTNM, clinical TNM; pTNM, pathological TNM.